Aberdeen Group’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.59M	Buy	285,288 +60,500	+27%	+$1.4M	0.01%	676
2025 Q1	$6.07M	Buy	224,788 +160,716	+251%	+$4.34M	0.01%	659
2024 Q4	$3.43M	Buy	+64,072	New	+$3.43M	0.01%	702